191 related articles for article (PubMed ID: 23639192)
21. Pueraria mirifica extract and puerarin enhance proliferation and expression of alkaline phosphatase and type I collagen in primary baboon osteoblasts.
Tiyasatkulkovit W; Malaivijitnond S; Charoenphandhu N; Havill LM; Ford AL; VandeBerg JL
Phytomedicine; 2014 Oct; 21(12):1498-503. PubMed ID: 25442257
[TBL] [Abstract][Full Text] [Related]
22. Puerarin inhibits TRPM3/miR-204 to promote MC3T3-E1 cells proliferation, differentiation and mineralization.
Zeng X; Feng Q; Zhao F; Sun C; Zhou T; Yang J; Zhan X
Phytother Res; 2018 Jun; 32(6):996-1003. PubMed ID: 29368357
[TBL] [Abstract][Full Text] [Related]
23. Puerarin protects pancreatic β-cell survival via PI3K/Akt signaling pathway.
Li Z; Shangguan Z; Liu Y; Wang J; Li X; Yang S; Liu S
J Mol Endocrinol; 2014 Aug; 53(1):71-9. PubMed ID: 24827001
[TBL] [Abstract][Full Text] [Related]
24. Puerarin Prevents LPS-Induced Osteoclast Formation and Bone Loss via Inhibition of Akt Activation.
Zhang Y; Yan M; Yu QF; Yang PF; Zhang HD; Sun YH; Zhang ZF; Gao YF
Biol Pharm Bull; 2016; 39(12):2028-2035. PubMed ID: 27904045
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of puerarin on vascular smooth muscle cells proliferation induced by oxidised low-density lipoprotein via suppressing ERK 1/2 phosphorylation and PCNA expression.
Hu Y; Liu K; Bo S; Yan M; Zhang Y; Miao C; Ren L
Pharmazie; 2016 Feb; 71(2):89-93. PubMed ID: 27004373
[TBL] [Abstract][Full Text] [Related]
26. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
27. Puerarin activates endothelial nitric oxide synthase through estrogen receptor-dependent PI3-kinase and calcium-dependent AMP-activated protein kinase.
Hwang YP; Kim HG; Hien TT; Jeong MH; Jeong TC; Jeong HG
Toxicol Appl Pharmacol; 2011 Nov; 257(1):48-58. PubMed ID: 21884717
[TBL] [Abstract][Full Text] [Related]
28. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
[TBL] [Abstract][Full Text] [Related]
29. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
30. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
Wu X; Li S; Xue P; Li Y
Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
32. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
[TBL] [Abstract][Full Text] [Related]
33. [Experimental study of the effects of puerarin on biological characters of osteoblasts in vitro].
Zang HM; Chen JC; Liu YH; Wang KZ
Zhongguo Zhong Yao Za Zhi; 2005 Dec; 30(24):1947-9. PubMed ID: 16494032
[TBL] [Abstract][Full Text] [Related]
34. Coenzyme Q10 promotes osteoblast proliferation and differentiation and protects against ovariectomy-induced osteoporosis.
Zheng D; Cui C; Yu M; Li X; Wang L; Chen X; Lin Y
Mol Med Rep; 2018 Jan; 17(1):400-407. PubMed ID: 29115467
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells.
Salvatori L; Caporuscio F; Coroniti G; Starace G; Frati L; Russo MA; Petrangeli E
J Cell Physiol; 2009 Jul; 220(1):35-44. PubMed ID: 19347870
[TBL] [Abstract][Full Text] [Related]
36. Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway.
Hsu YL; Kuo PL
J Bone Miner Res; 2008 Jun; 23(6):949-60. PubMed ID: 18269307
[TBL] [Abstract][Full Text] [Related]
37. Puerarin induced in mantle cell lymphoma apoptosis and its possible mechanisms involving multi-signaling pathway.
Gan M; Yin X
Cell Biochem Biophys; 2015 Jan; 71(1):367-73. PubMed ID: 25173778
[TBL] [Abstract][Full Text] [Related]
38. Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalpha.
Lam L; Hu X; Aktary Z; Andrews DW; Pasdar M
Breast Cancer Res Treat; 2009 Dec; 118(3):605-21. PubMed ID: 19002577
[TBL] [Abstract][Full Text] [Related]
39. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
40. Extrapancreatic roles of glimepiride on osteoblasts from rat manibular bone in vitro: Regulation of cytodifferentiation through PI3-kinases/Akt signalling pathway.
Ma P; Xiong W; Liu H; Ma J; Gu B; Wu X
Arch Oral Biol; 2011 Apr; 56(4):307-16. PubMed ID: 21055727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
